Navigation Links
firm in Medical Technology

Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP

RADNOR, Pa., Feb. 20 /PRNewswire/ -- The following statement was issued today by the law firm of Barroway Topaz Kessler Meltzer & Check, LLP: Notice is hereby given that a class action lawsuit was filed in the United States District Court for the Northern District of California on behalf ...

Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels

Dr. John A. Rumberger and KGK Synergize Will Study Ingredient's Impact on North Americans NEW YORK, Sept. 25 /PRNewswire/ -- Daiichi Fine Chemical Co., Ltd. of Japan today announced that it has selected world-renowned Cardiologist Dr. John A. Rumberger and the Contract Research Division of...

Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP

RADNOR, Pa., April 18 /PRNewswire/ -- The following statement was issued today by the law firm of Schiffrin Barroway Topaz & Kessler, LLP: Notice is hereby given that a class action lawsuit was filed in the United States District Court for the District of Massachusetts on behalf of all purch...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

... term biologic fixation with Trabecular M etal implants and could result in fewer and less complex revision procedures. "Few studies draw firm conclusions about the performance of cementless components in implants used in total hip arthroplasty, and for the most part, data about bone remodeli...

Relievant Medsystems Announces Completion of $20 Million Financing

...ith offices in Menlo Park, Boston and Boulder, the firm manages over $3 billion in capital and invests in ...ers Canaan Partners is a global venture capital firm specializing in early-stage life science and infor...ent Medical Partners is a life sciences investment firm that focuses on medical device and healthcare comp...

Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections

...are usually caused by gram-negative pathogens". Eckard Weber, president and chief executive officer of Calixa and partner at the venture capital firm Domain Associates, LLC said, "With the continually increasing incidence of serious and life-threatening infections caused by resistant gram-negative b...

GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting

...er Tsolinas. Additionally, stockholders ratified the appointment of Porter Keadle Moore LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2009. Don Hildebrand, company co-founder and Chairman of the Board of Directors, provided opening remarks...

CoAxia, Inc. Announces $21.5M Series D Financing

...ion augmentation. Sofinnova Partners is an independent venture capital firm based in Paris, France that specializes in investments in early stage compa...rate spin-offs in the technology and life sciences sectors. Since 1972, the firm has financed over 450 companies, many of which have gone public or have bee...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

...ctions. About Celtic Pharmaceutical Holdings L.P. Celtic Pharmaceutical Holdings L.P. (Celtic Pharma) is a global private equity investment firm focused on the biotechnology and pharmaceutical industries. Celtic Pharma was founded by Stephen Evans-Freke and John Mayo, CBE and is based in Bermu...

Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data

... BOSTON, May 23 /PRNewswire/ -- Amid all the speculation over what course the Swine Flu epidemic will take, Boston-based biotech firm Replikins Ltd. ( www.replikins.com ) last week analyzed the most recent peptide genomic sequence data available and determined that the infectivity ...

TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics

...very and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 90 scientists and other professionals. For more information about the firm and products, call 858-546-0004, email info@trilinkbiotech.com " target="_...

Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)

...19 placebo-treated patients. The size of the control group and limited duration of the controlled portions of the studies preclude the ability to draw firm conclusions. In studies of CIMZIA for Crohn's disease and other investigational uses, there was one case of lymphoma among 2,657 CIMZIA-treated patien...

BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available

...cs, LLC ( http://www.gene2drug.com ), the premier research and advisory firm serving the life science market, fielded a detailed 60-question survey to s...INFORMATICS, LLC BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social n...

Insurance Industry Teleconference on Swine Flu Pandemic Set for May 13

...May 4 /PRNewswire/ -- Just hours after the World Health Organization warned that a Swine Flu or A/H1N1 pandemic is imminent, a prominent insurance law firm announced it will host a teleconference for insurance executives working to address this urgent global risk. "As we've seen with everything from ...

Leader in Prostate Health Urges Prostate Cancer Screening in Face of Contradicting Data

...r that will eventually take their life. If caught early, through screening, these lives could be saved. Discouraging or withholding screening without firm evidence could cost men their lives." The PCEC encourages men to "Choose to Know - and Know to Choose." This means they should choose to know th...

Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update

...rance that the Company can achieve its projected operating results. Accordingly, the report of the Company's independent registered public accounting firm on the Company's financial statements for the year ended December 31, 2008 expresses substantial doubt about the Company's ability to continue as a go...

Virtual Colonoscopies Show Value for Some Patients, But Polyps Will Be Missed

...ts with large polyps and cancers that were identified by colonoscopy and between 76% and 95% of symptomatic patients with large polyps and cancers. No firm conclusions could be drawn regarding the proportion of asymptomatic high-risk patients with important polyps that would be identified by CT colonograp...

Got Pain?

...ly satisfied. Dupuytren's Disease ( http://orthoinfo.aaos.org/topic.cfm?topic=A00008 ) Often starts with lumps in the palm. firm cords begin to develop underneath the skin, stretching from the palm to the finger. Gradually, the cords cause the fingers to bend into the palm. ...

SynergEyes, Inc. Raises $13.3 Million in 'Series C' Financing

...ity Fund, believes the company has the potential to deliver a truly transformational vision correction product. "During the due diligence process, our firm realized the compelling value proposition SynergEyes offers not only patients, but also eye care practitioners," said Renee Masi, Managing Member of B...

American Dairy Provides Business Update

...viously announced, the Company engaged Grant Thornton, the Hong Kong member firm of Grant Thornton International, as its independent registered public accounting firm in 2008, and proactively initiated voluntary re-audits of the Company's fin...

Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

...r occupancy and as predicted from preclinical data, low doses of ITI-007 appear to occupy 5HT2A brain receptors and increase SWS. These data provide a firm base for projecting the expected efficacious dose range for ITI-007 as this drug is advanced in future studies for several indications, including SMI,...

ProUroCare Medical Inc. Announces Pricing of Equity Offering

...units to cover over-allotments, if any. The offering is expected to close on or about January 12, 2009. The offering is being underwritten on a firm commitment basis by Feltl and Company, Inc. Net proceeds of this offering will be used to fund certain operating expenses and development costs...

Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009

...ma. About Celtic Pharmaceutical Holdings L.P. Celtic Pharmaceutical Holdings L.P. (Celtic Pharma) is a global private equity investment firm focused on the biotechnology and pharmaceutical industries. Celtic Pharma was founded by Stephen Evans-Freke and John Mayo, CBE and is based in Bermu...

Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team

...and has elected to focus on his continued recovery from a previously disclosed diagnosis of acute leukemia. Orexigen has retained an executive search firm to assist it in finding a new, permanent CEO. In addition, Anthony McKinney, the Company's Chief Business Officer, and Frank Bymaster, the Company's ...

Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand

... backing and follow-on funding will enable Isogen to be the best positioned firm to meet the pent-up demand in biopharma for the unmet contract filling, con...ountry and has been widely regarded as an industry leader in the space. The firm also provides comprehensive wealth management services to executives and fa...

Lutonix Inc. Announces $20 Million Series B Financing

...tners ( http://www.usvp.com ) and founding venture firm RiverVest Venture Partners ( http://www.rivervest....stage and selective later-stage healthcare venture firm that has invested in 95 companies which have made ...California. Delphi Ventures is a venture capital firm that has focused on early stage investing in medic...

CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years

...19 placebo-treated patients. The size of the control group and limited duration of the controlled portions of the studies preclude the ability to draw firm conclusions. In studies of CIMZIA for Crohn's disease and other investigational uses, there was one case of lymphoma among 2,657 CIMZIA-treated patien...

Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years

.... The SPIRIT III trial was not designed to analyze statistical differences in any of the patient subgroups, as the sample sizes were too small to draw firm conclusions. "With the subgroup analysis, we saw encouraging trends of lower event rates between one and two years for patients treated with XIENCE ...

CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients

...19 placebo-treated patients. The size of the control group and limited duration of the controlled portions of the studies preclude the ability to draw firm conclusions. In studies of CIMZIA for Crohn's disease and other investigational uses, there was one case of lymphoma among 2,657 CIMZIA-treated patien...

CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients

...19 placebo-treated patients. The size of the control group and limited duration of the controlled portions of the studies preclude the ability to draw firm conclusions. In studies of CIMZIA for Crohn's disease and other investigational uses, there was one case of lymphoma among 2,657 CIMZIA-treated patien...

New Studies Highlight Benefits of Coblation(R)-Assisted Procedures in Airway Fire Prevention and Endoscopic Sinus Surgery

... periods being restated in the Company's previously announced restatement; the ability of the Company and its independent registered public accounting firm to confirm information or data identified in the review, being overseen by the Audit Committee of the Company's Board of Directors, of the scope and n...

Tobira Therapeutics Inc. Receives US Patent for TBR-652

...ercializing innovative antiviral compounds to treat HIV disease. The company was founded in 2006 by Eckard Weber, MD, a partner at the venture capital firm Domain Associates, to develop novel treatments for HIV disease. Tobira has assembled a highly experienced management team with decades of clinical and...

Aon eSolutions Launches Clinical Trials Module

...n brokerage revenues in 2007 and 2008, and was voted best insurance intermediary, best reinsurance intermediary, and best employee benefits consulting firm in 2007 by the readers of Business Insurance. For more information on Aon, log onto http://www.aon.com . Media Contact: Tammy Delatorre 661-...

Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders

...n brokerage revenues in 2007 and 2008, and was voted best insurance intermediary, best reinsurance intermediary, and best employee benefits consulting firm in 2007 by the readers of Business Insurance. For more information on Aon, log onto http://www.aon.com/ . Media contacts: Elly Krumwiede ...

BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment

... Pioneering firm marks milestone with initiatives aimed at knowledge transfer, including la... of Tufts University; Court Square Group, a Springfield-based IT consulting firm for life sciences; and Phase Forward of Waltham, a clinical trials software...

TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate

...-- Alan J. Tuchman, M.D., Clinical Professor of Neurology and Pharmacology at New York Medical College, Principal of a neuroscience-focused consulting firm and a board-certified neurologist Dr. Tuchman will present information about glutamate receptors in the spinal cord as a target for muscl...

Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease

...19 placebo-treated patients. The size of the control group and limited duration of the controlled portions of the studies preclude the ability to draw firm conclusions. In studies of Cimzia(R) for Crohn's disease and other investigational uses, there was one case of lymphoma among 2,657 Cimzia(R)-treated ...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.

...is a global market leader in this product area. About Crystal Research Associates, LLC Crystal Research Associates, LLC is an independent research firm that provides institutional-quality, fee-based research to small and mid-cap companies. Crystal Research Associates' unique and novel product, the Exe...

Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs

...elop new nitric oxide-donating antihypertensive agents using NicOx' proprietary technology These amounts, received by the Company, result from a firm commitment by the other contracting party and have been immediately recognized in revenues because NicOx will not have continuing involvement in the f...

Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema

...ech.com . About MPM: MPM Capital L.P. is a global investment management firm focused solely on life sciences investing. One of the largest investment ma...cts or those companies that already offer product-driven opportunities. The firm manages over $2.5 billion in assets through the MPM BioVentures Family of v...
Other Tags
(Date:3/23/2015)... 2015   HOYOS Labs , a leading global ... that the Company will demonstrate multiple biometrics-based technologies under ... at Connect:ID on March 23 through 25, 2015, in ... highlight the IEEE Biometric Open Protocol Standard; free biometrics-based ... access control system. BOPS was invented by HOYOS Labs ...
(Date:3/20/2015)... , Mar. 20, 2015 Research and Markets ... addition of the "India Sensors Market Forecast ... The sensor market is projected to ... Consumer electronics, automotive, industrial and healthcare ... in the country. In addition, adoption of MEMS ...
(Date:3/20/2015)... Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced the addition ... report to their offering. This report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
(Date:5/3/2015)... May 03, 2015 “ BolehVPN ” was ... which features the latest and coolest technology products available to ... NewsWatch, conducted the review and shared with viewers how to ... does these days is on computers and even more so ... and meet people all over the world. In terms of ...
(Date:5/3/2015)... It is not too late to register to ... Memory of Lissa Anne Been in Arnold, Missouri on May ... event to honor her loving memory. It has benefited the renowned ... having turned 37, Lissa suffered a brain aneurysm . After ... 2012. This event is designed to serve as a remembrance of ...
(Date:5/2/2015)... May 02, 2015 Vancouver fencing company, QS ... provide valuable advice to prospective clients related to their questions ... to install railings around their decks and patios. While that ... that pop up once the person rolls up their sleeve ... installing a railing in finding a gate that matches it. ...
(Date:5/2/2015)... Delray Beach, FL (PRWEB) May 02, 2015 ... newspaper has selected The Delray Recovery Center as one ... Recovery Center is known in the addiction treatment field ... encourages staff members to innovate and to continue their ... promoting a positive workplace environment, never forgetting their purpose ...
(Date:5/2/2015)... May 02, 2015 As a ... issues of the face, neck and décolleté, radiofrequency ... with real potential for the success of vulvovaginal ... ThermiHealth Clinical Advisory Council, ThermiGyn’s Women’s Health Clinical ... ACGE, concluded that ThermiGyn’s temperature controlled radio frequency, ...
Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3
Other Contents